Successful treatment of paraneoplastic cerebellar degeneration with Rituximab [3]

Journal of Neuro-Oncology

Volumn 86, Issue 3, 2008, Pages 363-364

  Esposito, Marcello ^a   Penza, P ^a   Orefice, G ^a   Pagano, A ^a   Parente, E ^a   Abbadessa, A ^b   Bonavita, V ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b AORN San Sebastiano   (Italy)

^c Istituto di Diagnosi e Cura Hermitage Capodimonte   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HU ANTIBODY; RITUXIMAB;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ATAXIA; BALANCE DISORDER; CANCER RELAPSE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DISEASE SEVERITY; DIZZINESS; DYSARTHRIA; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LETTER; LUNG SMALL CELL CANCER; NEUROLOGIC EXAMINATION; OCULOMOTOR NERVE DISEASE; PARANEOPLASTIC NEUROPATHY; STEM CELL TRANSPLANTATION;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; PARANEOPLASTIC CEREBELLAR DEGENERATION; TREATMENT OUTCOME;

EID: 38049025256     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9479-z     Document Type: Letter

References (9)

1. Dropcho EJ (2005) Update on paraneoplastic syndromes. Curr Opin Neurol 18:331-336
2. Shams'ili S, Grefkens J, de Leeuw B et al (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409-1418
3. Vernino S, O'Neill BP, Marks RS et al (2004) Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol 6:55-62
4. Pescovitz MD (2006) Rituximab, an Anti-CD20 monoclonal antibody: History and mechanism of action. Am J Transplant 6:859-866
5. Trouillas P, Takayanagi T, Hallett M et al (1997) International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The ataxia neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145:205-211
6. Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135-1140
7. Sillevis Smitt P, Grefkens J, de Leeuw B et al (2002) Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy J Neurol 249:745-753
8. Shams'ili S, de Beukelaar J, Gratama JW et al (2006) An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253:16-20
9. Dalakas MC (2006) B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target. Pharmacol Ther 112:57-70